[Registry] MSK-IMPACT/ACCESS Genomic Profiling in Cancer Patients
Condition: Cancer Diagnosis
Sponsor: Memorial Sloan Kettering Cancer Center
Protocol 12-245: Genomic Profiling in Cancer Patients
Genetic testing for patients with a cancer diagnosis or that are undergoing a work up to establish a potential cancer diagnosis. The primary objective of the trial is to determine the frequency of “actionable” oncogenic mutations in patients with solid or hematologic cancers being evaluated for treatment.
For more information you may contact the Research Department through the NYCBS HALO Messaging Center or call directly: 631-675-5075.